Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-LIPT1 Polyclonal Antibody is a Rabbit antibody targeting LIPT1. Anti-LIPT1 Polyclonal Antibody can be used in IHC-P,IHC-Fr,ICC/IF,IF.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 μL | $222 | 7-10 days | |
100 μL | $374 | 7-10 days | |
200 μL | $528 | 7-10 days |
Description | Anti-LIPT1 Polyclonal Antibody is a Rabbit antibody targeting LIPT1. Anti-LIPT1 Polyclonal Antibody can be used in IHC-P,IHC-Fr,ICC/IF,IF. |
Alias | mitochondrial, LIPT1, Lipoyltransferase 1, Lipoyl ligase, Lipoyl amidotransferase LIPT1, mitochondrial, Lipoate-protein ligase, Lipoate biosynthesis protein |
Ig Type | IgG |
Reactivity | (predicted:Human,Mouse,Rat,Dog,Cow,Horse,Rabbit,Sheep) |
Application | IHC-P,IHC-Fr,ICC/IF,IF |
Recommended Dose | IHC-P: 1:100-500; IHC-Fr: 1:100-500; ICC/IF: 1:100-500; IF: 1:100-500 |
Antibody Type | Polyclonal |
Host Species | Rabbit |
Subcellular Localization | Mitochondrion. |
Construction | Hybridoma Polyclonal Antibody |
Purification | Protein A purified |
Appearance | Liquid |
Formulation | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Research Background | The process of transferring lipoic acid to proteins is a two-step process. The first step is the activation of lipoic acid by lipoate-activating enzyme to form lipoyl-AMP. For the second step, the protein encoded by this gene transfers the lipoyl moiety to apoproteins. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 13. Read-through transcription also exists between this gene and the neighboring downstream mitochondrial ribosomal protein L30 (MRPL30) gene. [provided by RefSeq, Mar 2011] |
Immunogen | KLH conjugated synthetic peptide: human LIPT1 |
Antigen Species | Human |
Gene ID | |
Uniprot ID |
Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.